Denali Therapeutics (DNLI) FCF/share US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| FCF/share, rub | -1.81 | -2.09 | -2.70 | -2.21 | -2.41 | -2.25 | ||
| Changes by years, y/y, % | -148% | +16% | +29% | -18% | +9% | |||
Denali Therapeutics. FCF/share, rub
Denali Therapeutics. FCF/share, changes, %
Denali Therapeutics (DNLI) FCF/share US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF/share, rub | -0.80 | -0.46 | -0.61 | -0.57 | -0.72 | -2.25 | ||
| Changes by years, y/y, % | +3% | -18% | +65% | +9% | -10% | |||
| Changes by quarters, q/q, % | +53% | -42% | +32% | -7% | +26% | |||